Using advanced imaging techniques to detect lung disease early
Quantitative Optical Imaging Biomarkers of Interstitial Lung Disease
This study is looking at a new way to spot and track interstitial lung disease (ILD) earlier and more accurately using a special imaging technique combined with artificial intelligence, so patients can get better diagnoses and see how well their treatments are working.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11051879 on NIH RePORTER |
What this research studies
This research focuses on improving the early detection and monitoring of interstitial lung disease (ILD) using a technique called Optical Coherence Tomography (OCT). By combining OCT with artificial intelligence, the study aims to accurately identify and measure changes in lung tissue over time, allowing for better diagnosis and treatment evaluation. Patients will undergo minimally invasive imaging procedures, and the data collected will be analyzed to quantify disease progression in a more efficient manner. The goal is to enhance the ability to diagnose ILD early and assess how well treatments are working.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with interstitial lung disease who require ongoing monitoring of their condition.
Not a fit: Patients with other types of lung diseases or those who do not have interstitial lung disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and more effective monitoring of interstitial lung disease, improving patient outcomes.
How similar studies have performed: Previous research has shown that similar imaging techniques can effectively diagnose lung diseases, suggesting a promising avenue for this approach.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Nandy, Sreyankar — Massachusetts General Hospital
- Study coordinator: Nandy, Sreyankar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.